ArticleInternal medicine (Tokyo, Japan)2025
Lymphoproliferative Disorder in an Esophageal Cancer Patient Treated with Pembrolizumab.
Takashi Matsumura et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it